Compare Davita Inc (DVA) vs JPMorgan Equity Premium Income ETF (JEPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs JPMorgan Equity Premium Income ETF — how do they compare? Davita Inc trades at $175.04 (market cap $11.29B), while JPMorgan Equity Premium Income ETF trades at $56.71 (market cap $45.55B). The key difference: JPMorgan Equity Premium Income ETF is far larger — about 4× Davita Inc's market cap, and Davita Inc is trading nearer its 52-week high, JPMorgan Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and JPMorgan Equity Premium Income ETF for 56 Days on average.
| DVA | JEPI | |
|---|---|---|
Market Cap | $11.29B | $45.55B |
Volume | 582,204 | 3,820,809 |
Sector | Health | Income / Options Overlay |
52-Week High | $240.96 | $59.88 |
52-Week Low | $103.87 | $55.29 |
Typical Hold Time | 113 Days | 56 Days |
Enterprise Value | $24.01B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $176.78, down 2.01% today, showing technical bearish signals with price near key support at $175. Fundamentally, the company demonstrates solid earnings performance with three consecutive quarterly beats and attractive valuation metrics including a P/E of 14.98 and P/S of 0.88. Recent expansion of value-based care partnerships with Humana positions the company for continued growth in kidney care services.
The stock presents a compelling value opportunity with analyst consensus target of $235.67 offering 33% upside potential, though investors face risks from regulatory pressures and narrowing profit margins. Warren Buffett's significant ownership (45%) and institutional buying activity provide confidence, but the bearish technical outlook and mixed analyst ratings (43% Buy, 52% Hold) suggest cautious optimism is warranted.
JEPI trades at $56.45, down 0.16% with a bearish technical outlook. The ETF shows neutral momentum oscillators but bearish moving averages, with key support at $56 and resistance at $57. Recent dividend payments of $0.34-$0.37 highlight its income-focused strategy, though financial ratios remain undisclosed in current data.
JEPI's covered-call strategy provides monthly income but faces headwinds from Fed rate hikes and tax implications. Media sentiment is mixed, emphasizing income benefits versus growth trade-offs. Analyst coverage suggests cautious optimism given institutional inflows, though market volatility and income strategy limitations pose risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About JPMorgan Equity Premium Income ETF
JEPI is an actively managed ETF that seeks to deliver monthly income and stock market exposure with lower volatility. It combines an equity portfolio with an options strategy to generate steady premiums.
Read more on JEPI →
